Both treatments were originally made as weekly injectables, but the newer oral versions are a once-daily pill
Prevalence of diabetic cardiomyopathy in patients with type 2 diabetes in a large academic medical centre
Every drug program mentioned here was cross-checked against the global clinical trial databases, the public patent record, sponsor press releases, peer-reviewed journals, and the disclosed financial terms of every relevant deal
Available online at: (accessed April, 2026)
Gene and protein delivery platforms Nanocarrier-enabled delivery of macromolecules, including genes, small interfering RNAs (siRNAs), and proteins, represents a paradigm shift in GLP-1R-targeted therapy, providing prolonged or programmable effects that outperform conventional small-molecule approaches in duration, precision, and disease specificity [213, 425, 426]